Literature DB >> 11060588

The cancer patient with chronic pain due to herpes zoster.

S Modi1, J Pereira, J R Mackey.   

Abstract

Postherpetic neuralgia (PHN) is the most common complication of herpes zoster, and as such has been an area of extensive medical research for the past three decades. The patients at highest risk for PHN include those older than 50 years, those with severe acute cases of zoster, and those with shingles in a trigeminal distribution. As persons with malignancy are at a high risk for developing zoster itself, PHN is a complication that will be faced by many of these patients and their caregivers. This article reviews the available treatments and preventative measures for this debilitating condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060588     DOI: 10.1007/s11916-000-0066-7

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  59 in total

Review 1.  Postherpetic neuralgia--pathogenesis, treatment, and prevention.

Authors:  R G Kost; S E Straus
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

2.  Electrophysiological findings in peripheral fibres of subjects with and without post-herpetic neuralgia.

Authors:  M Mondelli; C Romano; P Della Porta; A Rossi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-06

3.  Herpes zoster infection after autologous bone marrow transplantation.

Authors:  L M Schuchter; J R Wingard; S Piantadosi; W H Burns; G W Santos; R Saral
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

4.  Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain.

Authors:  Ron C Kupers; Herman Konings; Hugo Adriaensen; Jan M Gybels
Journal:  Pain       Date:  1991-10       Impact factor: 6.961

5.  Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; H Weiss; J W Gnann; S Tyring; G J Mertz; P G Pappas; C J Schleupner; F Hayden; J Wolf; S J Soong
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391

6.  Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain.

Authors:  P L Dellemijn; J A Vanneste
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

7.  Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients.

Authors:  R J Whitley; S J Soong; R Dolin; R Betts; C Linnemann; C A Alford
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

8.  Amitriptyline versus placebo in postherpetic neuralgia.

Authors:  C P Watson; R J Evans; K Reed; H Merskey; L Goldsmith; J Warsh
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

9.  The response to epidural steroid injections in chronic dorsal root pain.

Authors:  J B Forrest
Journal:  Can Anaesth Soc J       Date:  1980-01

10.  Jaipur block in postherpetic neuralgia.

Authors:  R Bhargava; S Bhargava; K N Haldia; P Bhargava
Journal:  Int J Dermatol       Date:  1998-06       Impact factor: 2.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.